Biology of Blood and Marrow Transplantation
Volume 15, Issue 11 , Pages 1439-1446 , November 2009

Early and Late Neurological Complications after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation

  • Pere Barba

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
    • ,
  • Jose Luis Piñana

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
    • Corresponding Author InformationCorrespondence and reprint requests: Jose Luis Piñana, Hematology Department, Hospital de la Santa Creu i Sant Pau, St. Antoni Maria I Claret 167, Barcelona 08021, Spain.
    • ,
  • David Valcárcel

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
    • ,
  • Luis Querol

      Affiliations

    • Neurology Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
    • ,
  • Rodrigo Martino

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
    • ,
  • Anna Sureda

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
    • ,
  • Javier Briones

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
    • ,
  • Julio Delgado

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
    • ,
  • Salut Brunet

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
    • ,
  • Jorge Sierra

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain

Received 28 April 2009 ,Accepted 11 July 2009.

References 

  1. Valcárcel D, Martino R, Sureda A, et al. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies. Eur J Haematol. 2005;74:144–151
  2. Uckan D, Cetin M, Yigitkanli I, et al. Life-threatening neurological complications after bone marrow transplantation in children. Bone Marrow Transplant. 2005;35:71–76
  3. Siegal D, Keller A, Xu W, et al. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant. 2007;13:1369–1379
  4. Saiz A, Graus F. Neurological complications of hematopoietic cell transplantation. Semin Neurol. 2004;24:427–434
  5. Avivi I, Chakrabarti S, Kottaridis P, et al. Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation. Bone Marrow Transplant. 2004;34:137–142
  6. Kishi Y, Miyakoshi S, Kami M, et al. Early central nervous system complications after reduced-intensity stem cell transplantation. Biol Blood Marrow Transplant. 2004;10:561–568
  7. Sostak P, Padovan CS, Yousry TA, et al. A prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology. 2003;60:842–848
  8. Battle M, Oriol A, Ribera JM, et al. Neurologic complications following hematopoietic stem cell transplantation. Study of 14 patients. Med Clin (Barc). 2005;125:697–699
  9. Schmidt K, Schulz AS, Debatin KM, Friedrich W, Classen CF. CNS complications in children receiving chemotherapy or hematopoietic stem cell transplantation: retrospective analysis and clinical study of survivors. Pediatr Blood Cancer. 2008;50:331–336
  10. Narimatsu H, Miyamura K, Iida H, et al. Early central nervous complications after umbilical cord blood transplantation for adults. Biol Blood Marrow Transplant. 2009;15:92–100
  11. Valcárcel D, Martino R, Caballero D, et al. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. J Clin Oncol. 2008;26:577–584
  12. Martino R, Caballero MD, Canals C, et al. ALLOPBSCT Subcommittee of the Spanish Group for Haematopoietic Transplantation (GETH); Group GEL-TAMO. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study. Br J Haematol. 2001;115:653–659
  13. Pérez-Simón JA, Díez-Campelo M, Martino R, et al. Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation. Br J Haematol. 2005;130:394–403
  14. Weber C, Schaper J, Tibussek D, et al. Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantation. Bone Marrow Transplant. 2008;41:253–259
  15. Antonini G, Ceschin V, Morino S, et al. Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurology. 1998;50:1441–1445
  16. Adams HP, del Zoppo G, Alberts MJ, et al. American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655–1711
  17. Broderick J, Connolly S, Feldmann E, et al. American Heart Association/American Stroke Association Stroke Council; American Heart Association/American Stroke Association High Blood Pressure Research Council; Quality of Care and Outcomes in Research Interdisciplinary Working GroupGuidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007;116:e391–e413
  18. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47:1094–1120
  19. Klein JP, Rizzo JD, Zhang MJ, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant. 2001;28:909–915
  20. Klein JP, Rizzo JD, Zhang MJ, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling. Bone Marrow Transplant. 2001;28:1001–1111
  21. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  22. Bleggi-Torres LF, de Medeiros BC, Werner B, et al. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant. 2000;25:301–307
  23. Mathew RM, Rosenfeld MR. Neurologic complications of bone marrow and stem-cell transplantation in patients with cancer. Curr Treat Options Neurol. 2007;9:308–314
  24. McDonald JW, Goldberg MP, Gwag BJ, Chi SI, Choi DW. Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures. Ann Neurol. 1996;40:750–758
  25. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol. 1999;246:339–346
  26. Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int. 2000;13:313–326
  27. Sioka C, Kyritsis AP. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol. 2009;63:761–767

 Financial disclosure: See Acknowledgments on page 1445.

PII: S1083-8791(09)00342-5

doi: 10.1016/j.bbmt.2009.07.013

Biology of Blood and Marrow Transplantation
Volume 15, Issue 11 , Pages 1439-1446 , November 2009

Article Tools

* Image Usage & Resolution